| # | Drug | Count |
|---|---|---|
| 0 | SUNITINIB MALATE | 762 |
| 1 | AXITINIB | 210 |
| 2 | PAZOPANIB HYDROCHLORIDE | 175 |
| 3 | EVEROLIMUS | 143 |
| 4 | SORAFENIB | 104 |
| 5 | OMEPRAZOLE MAGNESIUM | 101 |
| 6 | CABOZANTINIB | 96 |
| 7 | AMLODIPINE | 95 |
| 8 | FUROSEMIDE | 90 |
| 9 | ASPIRIN | 80 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SUNITINIB MALATE | 762 | 0.0195 |
| 1 | TEMSIROLIMUS | 78 | 0.0173 |
| 2 | AXITINIB | 210 | 0.0107 |
| 3 | PAZOPANIB HYDROCHLORIDE | 175 | 0.0065 |
| 4 | SORAFENIB | 104 | 0.0050 |
| 5 | EVEROLIMUS | 143 | 0.0029 |
| 6 | EVEROLIMUS TABLETS | 46 | 0.0027 |
| 7 | ERGOCALCIFEROL | 74 | 0.0025 |
| 8 | CABOZANTINIB | 96 | 0.0020 |
| 9 | OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN | 21 | 0.0017 |
| # | Drug class | Count |
|---|---|---|
| 0 | Kinase Inhibitor [EPC] | 459 |
| 1 | Corticosteroid [EPC] | 149 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 144 |
| 3 | mTOR Inhibitor Immunosuppressant [EPC] | 144 |
| 4 | Dihydropyridine Calcium Channel Blocker [EPC] | 109 |
| 5 | Loop Diuretic [EPC] | 97 |
| 6 | Calcium Channel Blocker [EPC] | 95 |
| 7 | Opioid Agonist [EPC] | 93 |
| 8 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 92 |
| 9 | Proton Pump Inhibitor [EPC] | 88 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Lymphocyte Growth Factor [EPC] | 8 | 0.0063 |
| 1 | Provitamin D2 Compound [EPC] | 74 | 0.0025 |
| 2 | Cannabinoid [EPC] | 8 | 0.0010 |
| 3 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 92 | 0.0009 |
| 4 | Kinase Inhibitor [EPC] | 459 | 0.0008 |
| 5 | Interferon gamma [EPC] | 1 | 0.0007 |
| 6 | Calcitonin [EPC] | 2 | 0.0006 |
| 7 | Bismuth [EPC] | 3 | 0.0005 |
| 8 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 9 | Non-Standardized Fungal Allergenic Extract [EPC] | 1 | 0.0005 |